NCT07071207

Brief Summary

The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Sep 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Sep 2025May 2028

First Submitted

Initial submission to the registry

March 7, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 17, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

November 6, 2025

Status Verified

November 1, 2025

Enrollment Period

2.6 years

First QC Date

March 7, 2025

Last Update Submit

November 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to Recovery to Continence

    The time it takes for participants to recover continence, as defined by two successive M-ISI Pad Use Subdomain Scores of ≤ 2. The Pad Use Subdomain Score is determined by the sum of items Q7-8 from the M-ISI questionnaire, assessed as a time-to-event outcome.

    From baseline until the participant reaches two successive M-ISI Pad Use Subdomain Scores of ≤ 2, assessed up to 12 months

Study Arms (4)

Control group - LEP surgery patients

NO INTERVENTION

Patients undergoing LEP surgery and standard of care discharge instructions to perform pelvic floor exercises

Intervention group - LEP surgery patients

EXPERIMENTAL

Patient undergoing LEP surgery with text message intervention to perform pelvic floor exercises as described in the schedule of events

Behavioral: Text message reminders

Control group - RALP surgery patients

NO INTERVENTION

Patients undergoing RALP surgery and standard of care discharge instructions to perform pelvic floor exercises

Intervention group - RALP surgery patients

EXPERIMENTAL

Patient undergoing RALP surgery with text message intervention to perform pelvic floor exercises as described in the schedule of events

Behavioral: Text message reminders

Interventions

daily 8am text messages reminding patients to perform Kegel exercises as per their standard-of-care post-operative discharge instructions.

Intervention group - LEP surgery patientsIntervention group - RALP surgery patients

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure
  • Patient of URMC Urology
  • Adult male 18 years of age and older
  • Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted)
  • Has access to a mobile device capable of receiving automated text messages.
  • Willing to receive text messages and to complete questionnaires via SMS text.
  • Willingness to participate and able to provide informed consent.

You may not qualify if:

  • Less than 18 years of age
  • Unable to send and receive SMS texts
  • Unable to read, write, and speak English
  • Catheter dependency
  • Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period
  • In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

158 Sawgrass clinic; Suite 3100

Rochester, New York, 14620, United States

RECRUITING

MeSH Terms

Conditions

Urinary Incontinence, StressProstatic NeoplasmsProstatic Hyperplasia

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsGenital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesProstatic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

March 7, 2025

First Posted

July 17, 2025

Study Start

September 15, 2025

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

November 6, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations